153 related articles for article (PubMed ID: 16714752)
1. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques.
Milano MT; Garofalo MC; Chmura SJ; Farrey K; Rash C; Heimann R; Jani AB
Br J Radiol; 2006 Jun; 79(942):497-503. PubMed ID: 16714752
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.
Knab B; Rash C; Farrey K; Jani AB
Med Dosim; 2006; 31(4):292-7. PubMed ID: 17134669
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
[TBL] [Abstract][Full Text] [Related]
5. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y
Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.
Verbakel WF; van Reij E; Ladenius-Lischer I; Cuijpers JP; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e297-303. PubMed ID: 22579380
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy for gastric cancer: A dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans.
Dahele M; Skinner M; Schultz B; Cardoso M; Bell C; Ung YC
Med Dosim; 2010; 35(2):115-21. PubMed ID: 19931023
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric parameters predictive of acute gastrointestinal toxicity in patients with anal carcinoma treated with concurrent chemotherapy and intensity-modulated radiation therapy.
DeFoe SG; Kabolizadeh P; Heron DE; Beriwal S
Oncology; 2013; 85(1):1-7. PubMed ID: 23736101
[TBL] [Abstract][Full Text] [Related]
11. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161
[TBL] [Abstract][Full Text] [Related]
13. IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer.
Trip AK; Nijkamp J; van Tinteren H; Cats A; Boot H; Jansen EP; Verheij M
Radiother Oncol; 2014 Aug; 112(2):289-94. PubMed ID: 25241995
[TBL] [Abstract][Full Text] [Related]
14. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
15. Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer.
Alani S; Soyfer V; Strauss N; Schifter D; Corn BW
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):562-6. PubMed ID: 19427558
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.
Milano MT; Jani AB; Farrey KJ; Rash C; Heimann R; Chmura SJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):354-61. PubMed ID: 16168830
[TBL] [Abstract][Full Text] [Related]
17. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
18. Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.
Boda-Heggemann J; Hofheinz RD; Weiss C; Mennemeyer P; Mai SK; Hermes P; Wertz H; Post S; Massner B; Hieber U; Hochhaus A; Wenz F; Lohr F
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1187-95. PubMed ID: 19409725
[TBL] [Abstract][Full Text] [Related]
19. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
